Genmab A/S

Genmab A/S Dividend Growth

Year-over-Year Dividend Growth of Genmab A/S (GMAB.CO) as of Nov 10, 2026.

Dividend Growth

-

Last updated:

Year-over-Year Dividend Growth of Genmab A/S is 2026 - . Year-over-Year Dividend Growth of Genmab A/S was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Genmab A/S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Genmab A/S

All Key Metrics — Genmab A/S